2016
DOI: 10.3892/ol.2016.4735
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET

Abstract: Abstract. MicroRNA (miRNA)-based targeting in cancer has emerged as a potential therapeutic strategy. miR-206 has recently been implicated in cancer. However, the role and molecular mechanism of miR-206 in lung adenocarcinoma are still unclear. The present study revealed that miR-206 was downregulated in human lung adenocarcinoma tissues. Overexpression of miR-206 in human lung adenocarcinoma-derived cells significantly inhibited cell viability and migration. Further experiments indicated that the overexpressi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
15
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 31 publications
3
15
0
Order By: Relevance
“…From our results and others, we can find that c‐Met targeting is the common character in these studies, although the experiments were conducted under different gefitinib‐resistant conditions. Previous studies showed that miR‐206 target c‐Met directly in lung cancer cells . In our study, we further demonstrated that both miR‐1‐3p and miR‐206 have common target c‐Met in EGFR mutant PC‐9 and HCC‐827 cells.…”
Section: Discussionsupporting
confidence: 79%
See 1 more Smart Citation
“…From our results and others, we can find that c‐Met targeting is the common character in these studies, although the experiments were conducted under different gefitinib‐resistant conditions. Previous studies showed that miR‐206 target c‐Met directly in lung cancer cells . In our study, we further demonstrated that both miR‐1‐3p and miR‐206 have common target c‐Met in EGFR mutant PC‐9 and HCC‐827 cells.…”
Section: Discussionsupporting
confidence: 79%
“…Previous studies showed that miR-206 target c-Met directly in lung cancer cells. 44 In our study, we further demonstrated that both miR-1-3p and miR-206 have common Epithelial-mesenchymal transition is another mechanism of acquired EGFR-TKI resistance in lung cancers. In vitro studies showed that the mesenchymal phenotype is more resistant to EGF-TKI than the epithelial phenotype.…”
Section: Discussionsupporting
confidence: 68%
“…Wang, et al also revealed that miR-206 overexpression promoted neural cell apoptosis by regulating Otx2, one of its target genes [27]. Furthermore, cell migration is a crucial step in cancer metastasis, and a previous study revealed that upregulation of miR-206 in lung adenocarcinoma cells inhibits cell migration [28]. In line with our results, another study also demonstrated that miR-206 might play a key role in the pathogenesis and development of OS and may provide a potential target for gene therapy [9].…”
Section: Discussionmentioning
confidence: 99%
“…miRNAs negatively modulate gene expression through binding to the 3'-untranslated regions (3'UTRs) of the target genes in base pairing manner and therefore resulting in either translation suppression or corresponding mRNAs degradation (12). Accumulated studies have reported that miRNAs regulate approximately one third to as many as two thirds of human genes and are involved in a number of cellular biological processes, such as cell proliferation, apoptosis, metabolism, immunity and metastasis (13)(14)(15). To date, multiple miRNAs have been found to be abnormally expressed in NSCLC, such as miR-124 (16), miR-154 (17), miR-320 (18), miR-485 (19) and so on.…”
Section: Introductionmentioning
confidence: 99%